Evidence for a 1,25-dihydroxyvitamin D3 receptor-like macromolecule in rat pituitary

Mark R Haussler, S. C. Manolagas, L. J. Deftos

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), acts by binding initially to cytoplasmic receptors in target cells. Although 1,25(OH)2D3 receptors have been well characterized in peripheral mineral translocating tissues like intestine, bone, and kidney, little information beyond autoradiographic analysis is available on the possible binding of 1,25(OH)2D3 in central regulatory sites such as brain. Of particular interest is the pituitary gland since growth hormone and prolactin are thought to affect 1,25(OH)2D3 biosynthesis in kidney. We have utilized sucrose gradient sedimentation, saturation analysis, and DNA-cellulose chromatography to show here that normal rat pituitary cytosol contains a receptor-like component which binds 1,25(OH)2D3 with specificity and high affinity (K(d)=5x10-10 M). This macromolecule sediments at 3.3 S in high salt sucrose gradients, but is difficult to demonstrate in cytosol prepared from whole pituitaries because of excessive contamination by a 5.8 S serum-derived protein that binds the hormone as well as its 25-hydroxyvitamin D3 precursor. Enhancement of the 3.3 S 1,25(OH)2D3 binder relative to the 5.8 S protein can be achieved by incubating pituitary quarters with labeled hormone and washing prior to preparation of cytosol. However, the clearest demonstration of the 3.3 S receptor for 1,25(OH)2D3 results when freshly dispersed anterior pituitary cells serve as the source of cytosol. The receptor-like component also adsorbs to DNA-cellulose and elutes at a KCl concentration (0.25 M) identical with that of rat kidney cytosol receptor for 1,25(OH)2D3. Since this receptor-like molecule has biochemical properties very similar to that of other 1,25(OH)2D3 receptors, we suggest that the 1,25(OH)2D3 hormone may function in the pituitary gland.

Original languageEnglish (US)
Pages (from-to)5007-5010
Number of pages4
JournalJournal of Biological Chemistry
Volume255
Issue number11
StatePublished - 1980
Externally publishedYes

Fingerprint

Calcitriol Receptors
Macromolecules
Cytosol
Rats
Hormones
Sucrose
Calcifediol
Pituitary Gland
Kidney
Calcitriol
Protein S
Biosynthesis
Cytoplasmic and Nuclear Receptors
Chromatography
Sedimentation
Washing
Vitamin D
Prolactin
Growth Hormone
Binders

ASJC Scopus subject areas

  • Biochemistry

Cite this

Evidence for a 1,25-dihydroxyvitamin D3 receptor-like macromolecule in rat pituitary. / Haussler, Mark R; Manolagas, S. C.; Deftos, L. J.

In: Journal of Biological Chemistry, Vol. 255, No. 11, 1980, p. 5007-5010.

Research output: Contribution to journalArticle

@article{3acbaeb5aa9f4e248bef43c4e1bfd6f5,
title = "Evidence for a 1,25-dihydroxyvitamin D3 receptor-like macromolecule in rat pituitary",
abstract = "The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), acts by binding initially to cytoplasmic receptors in target cells. Although 1,25(OH)2D3 receptors have been well characterized in peripheral mineral translocating tissues like intestine, bone, and kidney, little information beyond autoradiographic analysis is available on the possible binding of 1,25(OH)2D3 in central regulatory sites such as brain. Of particular interest is the pituitary gland since growth hormone and prolactin are thought to affect 1,25(OH)2D3 biosynthesis in kidney. We have utilized sucrose gradient sedimentation, saturation analysis, and DNA-cellulose chromatography to show here that normal rat pituitary cytosol contains a receptor-like component which binds 1,25(OH)2D3 with specificity and high affinity (K(d)=5x10-10 M). This macromolecule sediments at 3.3 S in high salt sucrose gradients, but is difficult to demonstrate in cytosol prepared from whole pituitaries because of excessive contamination by a 5.8 S serum-derived protein that binds the hormone as well as its 25-hydroxyvitamin D3 precursor. Enhancement of the 3.3 S 1,25(OH)2D3 binder relative to the 5.8 S protein can be achieved by incubating pituitary quarters with labeled hormone and washing prior to preparation of cytosol. However, the clearest demonstration of the 3.3 S receptor for 1,25(OH)2D3 results when freshly dispersed anterior pituitary cells serve as the source of cytosol. The receptor-like component also adsorbs to DNA-cellulose and elutes at a KCl concentration (0.25 M) identical with that of rat kidney cytosol receptor for 1,25(OH)2D3. Since this receptor-like molecule has biochemical properties very similar to that of other 1,25(OH)2D3 receptors, we suggest that the 1,25(OH)2D3 hormone may function in the pituitary gland.",
author = "Haussler, {Mark R} and Manolagas, {S. C.} and Deftos, {L. J.}",
year = "1980",
language = "English (US)",
volume = "255",
pages = "5007--5010",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Evidence for a 1,25-dihydroxyvitamin D3 receptor-like macromolecule in rat pituitary

AU - Haussler, Mark R

AU - Manolagas, S. C.

AU - Deftos, L. J.

PY - 1980

Y1 - 1980

N2 - The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), acts by binding initially to cytoplasmic receptors in target cells. Although 1,25(OH)2D3 receptors have been well characterized in peripheral mineral translocating tissues like intestine, bone, and kidney, little information beyond autoradiographic analysis is available on the possible binding of 1,25(OH)2D3 in central regulatory sites such as brain. Of particular interest is the pituitary gland since growth hormone and prolactin are thought to affect 1,25(OH)2D3 biosynthesis in kidney. We have utilized sucrose gradient sedimentation, saturation analysis, and DNA-cellulose chromatography to show here that normal rat pituitary cytosol contains a receptor-like component which binds 1,25(OH)2D3 with specificity and high affinity (K(d)=5x10-10 M). This macromolecule sediments at 3.3 S in high salt sucrose gradients, but is difficult to demonstrate in cytosol prepared from whole pituitaries because of excessive contamination by a 5.8 S serum-derived protein that binds the hormone as well as its 25-hydroxyvitamin D3 precursor. Enhancement of the 3.3 S 1,25(OH)2D3 binder relative to the 5.8 S protein can be achieved by incubating pituitary quarters with labeled hormone and washing prior to preparation of cytosol. However, the clearest demonstration of the 3.3 S receptor for 1,25(OH)2D3 results when freshly dispersed anterior pituitary cells serve as the source of cytosol. The receptor-like component also adsorbs to DNA-cellulose and elutes at a KCl concentration (0.25 M) identical with that of rat kidney cytosol receptor for 1,25(OH)2D3. Since this receptor-like molecule has biochemical properties very similar to that of other 1,25(OH)2D3 receptors, we suggest that the 1,25(OH)2D3 hormone may function in the pituitary gland.

AB - The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), acts by binding initially to cytoplasmic receptors in target cells. Although 1,25(OH)2D3 receptors have been well characterized in peripheral mineral translocating tissues like intestine, bone, and kidney, little information beyond autoradiographic analysis is available on the possible binding of 1,25(OH)2D3 in central regulatory sites such as brain. Of particular interest is the pituitary gland since growth hormone and prolactin are thought to affect 1,25(OH)2D3 biosynthesis in kidney. We have utilized sucrose gradient sedimentation, saturation analysis, and DNA-cellulose chromatography to show here that normal rat pituitary cytosol contains a receptor-like component which binds 1,25(OH)2D3 with specificity and high affinity (K(d)=5x10-10 M). This macromolecule sediments at 3.3 S in high salt sucrose gradients, but is difficult to demonstrate in cytosol prepared from whole pituitaries because of excessive contamination by a 5.8 S serum-derived protein that binds the hormone as well as its 25-hydroxyvitamin D3 precursor. Enhancement of the 3.3 S 1,25(OH)2D3 binder relative to the 5.8 S protein can be achieved by incubating pituitary quarters with labeled hormone and washing prior to preparation of cytosol. However, the clearest demonstration of the 3.3 S receptor for 1,25(OH)2D3 results when freshly dispersed anterior pituitary cells serve as the source of cytosol. The receptor-like component also adsorbs to DNA-cellulose and elutes at a KCl concentration (0.25 M) identical with that of rat kidney cytosol receptor for 1,25(OH)2D3. Since this receptor-like molecule has biochemical properties very similar to that of other 1,25(OH)2D3 receptors, we suggest that the 1,25(OH)2D3 hormone may function in the pituitary gland.

UR - http://www.scopus.com/inward/record.url?scp=0019304053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019304053&partnerID=8YFLogxK

M3 - Article

C2 - 6246092

AN - SCOPUS:0019304053

VL - 255

SP - 5007

EP - 5010

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 11

ER -